| Identifier |
20230312_nanos_posters_209 |
| Title |
Real World Experience with Teprotumumab in Patients with Dysthyroid Optic Neuropathy (DON) |
| Creator |
Madhura Tamhankar; Alvin Relucio |
| Affiliation |
(MT) Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA; (AR) Horizon Therapeutics |
| Subject |
Optic Neuropathy; Orbit/Ocular Pathology; Graves' Disease |
| Description |
Teprotumumab, an insulin-like growth factor I receptor inhibitory antibody, improved proptosis, diplopia, inflammatory signs/symptoms, and quality of life (QOL) in patients with active thyroid eye disease (TED) in clinical trials.1,2 The trials excluded patients with DON, and the effect of teprotumumab is not well understood in this population. Here we summarize findings from the literature and our clinical experience in treating such patients with teprotumumab. |
| Date |
2023-03-14 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2023 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2023: Poster Session I: Orbital and Eyelid Disorders |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6z1v87s |
| Setname |
ehsl_novel_nam |
| ID |
2335414 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6z1v87s |
